![]() |
市场调查报告书
商品编码
1375211
南美洲和中美洲生物製程技术市场预测至 2028 年 - 按类型、模式和最终用户进行的区域分析South & Central America Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User |
南美洲和中美洲生物製程技术市场预计将从2023年的15.3147亿美元成长到2028年的33.6113亿美元。预计2023年至2028年复合年增长率为17.0%。
引进先进的生物製程技术推动南美洲和中美洲生物製程技术市场
先进的生物製程技术将研发与生产连结起来。一些参与者正在市场上引入各种新的生物加工技术。 2020 年 12 月 4 日,IDBS(生物技术和製药行业软体资讯学解决方案提供商)宣布推出 Polar。 Polar 创建了一个名为生物製药生命週期管理 (BPLM) 的新产品类别,以简化生物製药研究中的药物开发和生产。 Polar 的设计和部署旨在快速解决与工作流程、流程品质、协作和资料分析相关的挑战,这些挑战一直困扰着现有的软体解决方案,包括实验室资讯管理系统(LIMS) 和电子实验室笔记本(ELN)。因此,人为错误将会减少,整体准确度也会提高。它将减少手动资料处理和转录,从而减少人为错误并提高整体准确性。它还具有广泛的搜寻功能,使用户可以更轻鬆地找到他们正在搜寻的内容,从而避免无意义的重复工作。
梅特勒-托利多的 Dynochem Biologics 是一款专用模拟软体,支援任何规模的生物加工中的上游和下游单元活动。生物製程工程师和科学家使用该软体选择适当的製程操作参数并建立等效规模。实用程式可以用最少的资料快速评估设备性能,而更有效的模型则利用现有的资料流进行製程表征。透过快速回应的应用专业知识、丰富的培训资源和已建置的模型库,可以快速完成初始专案。胜肽、单株抗体、疫苗接种和病毒载体只是众多应用中的几个例子。
默克的全新 BioContinuum 平台透过提高效率、简化工厂运作以及更高的品质和一致性来推进生物治疗药物的生产。此外,默克的 Pellicon 单通道切向流过滤有助于强化与治疗性蛋白质纯化相关的操作。因此,各种新时代生物工艺技术的引入可能会在预测期内为市场成长提供利润丰厚的机会。
南美洲和中美洲生物製程技术市场概况
根据美国国立卫生研究院 (NIH) 的报告,生物製程活动使用巴西菌株生产纯化蛋白衍生物 (PPD),用于诊断用途。在巴西,医疗保健系统在各个地区进口和分发 PPD。进行 PPD 的本土生产是为了启动研究,利用从巴西各地结核病患者体内分离出的结核分枝桿菌菌株来开发本土 PPD 生产技术。因此,PPD 在单独测试时显示出类似的迹象,并且获得了更好的结果。透过菌株生产用于标靶治疗的菌株的这种进步是预测期内南美洲和中美洲生物製程技术市场显着增长的原因。
南美洲及中美洲生物製程技术市场收入及 2028 年预测(百万美元)
南美洲和中美洲生物製程技术市场细分
南美洲和中美洲生物製程技术市场按类型、模式、最终用户和国家进行细分。
根据类型,南美洲和中美洲生物製程技术市场分为细胞培养基生物製程、色谱生物製程、消耗品和配件等。 2023年,消耗品和配件领域在南美洲和中美洲生物製程技术市场中占据最大份额。
根据形态,南美洲和中美洲生物加工技术市场分为一次性使用和多次使用。 2023 年,一次性细分市场在南美洲和中美洲生物製程技术市场中占据更大份额。
根据最终用途,南美洲和中美洲生物製程技术市场分为学术和医疗机构、生物製药公司、研究实验室等。 2023年,生物製药公司细分市场在南美洲和中美洲生物製程技术市场中占据最大份额。
根据国家/地区,南美洲和中美洲生物製程技术市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2023 年,南美洲和中美洲其他地区在南美洲和中美洲生物製程技术市场中占据最大份额。
丹纳赫公司;艾本德公司;龙沙集团股份公司;默克公司;雷普利根公司;赛多利斯公司;和赛默飞世尔科技公司是南美洲和中美洲生物製程技术市场上的一些主要公司。
The South & Central America bioprocess technology market is expected to grow from US$ 1,531.47 million in 2023 to US$ 3,361.13 million by 2028. It is estimated to grow at a CAGR of 17.0% from 2023 to 2028.
Introducing Advanced Bioprocess Technologies Drives South & Central America Bioprocess Technology Market
Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort.
METTLER TOLEDO's Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications.
Merck's new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck's Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.
South & Central America Bioprocess Technology Market Overview
The bioprocess activity produces purified protein derivative (PPD) using Brazilian strains intended for diagnostic use, per the National Institute of Health (NIH) report. In Brazil, the healthcare system imports and distributes the PPD across various areas. The indigenous production of PPD was undertaken to initiate studies toward developing an indigenous technology for PPD production using the strains of Mycobacterium tuberculosis isolated from patients suffering from TB across Brazil. Therefore, PPD reveals similar indications when tested individually, and better results were obtained. Such advancements in producing strains for targeted therapy through strains are responsible for significant growth for the South & Central America bioprocess technology market during the forecast period.
South & Central America Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Bioprocess Technology Market Segmentation
The South & Central America bioprocess technology market is segmented into type, modality, end user, and country.
Based on type, the South & Central America bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the South & Central America bioprocess technology market.
Based on modality, the South & Central America bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the South & Central America bioprocess technology market.
Based on end-use, the South & Central America bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the South & Central America bioprocess technology market.
Based on country, the South & Central America bioprocess technology market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2023, the Rest of South & Central America segment registered a largest share in the South & Central America bioprocess technology market.
Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the key companies operating in the South & Central America bioprocess technology market.